Google Health CLI now available to access your data & build tools

9to5google.com Jul 1, 2026

Google Health CLI now available to access your data & build tools

Curated by Shubham · TechCapsules · Jul 1, 2026

AI-summarised brief · reviewed before publication

Google Health now offers a command-line interface (CLI) that allows users to access their health and wellness data from devices like the Fitbit Air and Pixel Watch. The CLI provides access to over 40 health metrics, which can be exported in various formats, including JSON, CSV, and custom dashboards. The tool is designed for both commercial application developers and individual health enthusiasts, with two starter skills for streamlined setup and authentication.

💡 Why It Matters

· The Google Health CLI empowers users to take control of their health data, enabling them to build personalized tools and insights that can inform their wellness decisions.
· By providing a seamless interface for accessing and analyzing health metrics, the CLI has the potential to revolutionize the way individuals manage their health and wellness.

Read full article on 9to5google.com

Does the Fitbit Air support automatic activity detection?

The Google Fitbit Air is a screenless fitness tracker that automatically detects and saves activities in the background. These activities appear in the Google Health app, where users can confirm, change, or delete them. The tracker's algorithm adapts based on usage, giving preference to tracked activity types. It monitors health metrics, including heart rate, steps, and cardio load, to determine when the user is physically active. The app allows users to customize activity types and minimum durations for automatically recorded activities.

💡 Google's automatic activity detection feature may not always be accurate, and manual confirmation in the Google Health app can improve results. By calibrating the Fitbit Air with a 10-minute outdoor walking workout, users can enhance the accuracy of automatically detected activity data.

artificialintelligence-news.com · Jul 3

Takeda signs US$600M AI drug discovery deal with Insilico

Takeda has entered a strategic collaboration with Insilico Medicine to use AI in early-stage drug discovery. The agreement gives Takeda access to Insilico's Pharma.AI platform, which supports target identification, molecular design, and clinical trial prediction. Insilico will lead AI-driven discovery work, while Takeda will advance selected candidates through clinical development. The deal includes $60 million in project initiation fees and milestones, with a potential total value of $600 million if milestones are achieved. Takeda will receive exclusive worldwide rights to develop and commercialize novel therapeutics. Insilico is also eligible for tiered royalties on future sales, supporting early-stage research and development.

💡 The deal accelerates Takeda's integration of AI in drug discovery, combining its disease biology expertise with Insilico's AI capabilities. It also underscores Insilico's growing influence in AI-powered drug discovery, with collaborations now valued at over $7 billion.

industrialnews.co.uk · Jul 3

GE HealthCare expands Allia upgrade route

GE HealthCare has introduced upgrade pathways for selected legacy Innova and Discovery image guiding solutions, allowing hospitals to modernize interventional suites without replacing infrastructure. The upgrades extend the value of existing systems with workflow improvements, interoperability, and access to Allia innovations. Available upgrades include AI-enabled image reconstruction and predictive maintenance capabilities. The approach helps customers preserve infrastructure, avoid construction work, and reduce disruption to clinical operations. The upgrades are available in the US and other markets where Allia systems are approved. This move reflects a shift in medical technology towards modernizing installed bases.

💡 By offering upgrade pathways, GE HealthCare addresses the challenge of aging interventional X-ray systems, which can lack modern features like better image quality and AI-enabled tools. Hospitals can now stage investments in newer technology without undertaking full replacements.

neowin.net · Jul 1

Fitbit Inspire 3 health and fitness tracker is selling at its lowest…

Amazon is offering the Fitbit Inspire 3 health and fitness tracker at its lowest price with a 34% discount. The device features an AMOLED touchscreen display, a range of sensors, including a heart rate monitor and blood oxygen level sensor, and supports Bluetooth LE syncing. It stores up to seven days of activity data, has a 5 ATM water rating, and provides up to 10 days of battery life on a single charge. The tracker is compatible with iPhones and Android smartphones running specific operating systems and requires the Google Health app for setup and use.

💡 The discounted price of the Fitbit Inspire 3 makes it an attractive option for those on a budget, potentially increasing its adoption rate among consumers who want a high-end fitness tracker without the premium price tag. This could lead to a larger market share for Fitbit and further solidify its position in the wearable technology industry.

prnewswire.co.uk · Jul 1

Basecamp Research brings EDEN’s antibiotic and vaccine design models to Claude Science

Basecamp Research has integrated its EDEN models, which design potent antibiotics and predict vaccine targets, into Claude Science, a life sciences research platform. This integration allows researchers to generate and prioritize therapeutic candidates through a conversational interface in minutes. The EDEN models have been tested in the lab and shown to be effective against World Health Organisation priority pathogens, including a multidrug-resistant pathogen associated with hospital outbreaks worldwide. The integration aims to accelerate antibiotic discovery and vaccine development, addressing the growing threat of antimicrobial resistance.

💡 The integration of EDEN models into Claude Science has the potential to revolutionize the fight against antimicrobial resistance, which is responsible for nearly 5 million deaths per year. By enabling researchers to design new antibiotics and vaccines in minutes, rather than years, this collaboration could save countless lives and provide a crucial tool in the battle against emerging pathogens.

androidheadlines.com · Jul 1

New Bill Aims to Stop Chatbots from Selling Your Health Data

Senator Elizabeth Warren and Representative Mary Gay Scanlon have introduced a revamped version of the Health and Location Data Protection Act to ban AI corporations and data brokers from selling sensitive personal health inputs. The updated bill targets the growing trend of tech companies encouraging users to upload medical records to systems like ChatGPT and Grok. If passed, the legislation would provide $1 billion over ten years to the FTC for enforcement, addressing a legal loophole in federal frameworks. The move comes as tech labs transform chatbots into medical hubs, encouraging consumers to feed them raw biological data, prompting lawmakers to act.

💡 By closing this loophole, lawmakers can prevent the unchecked commercialization of sensitive medical information. This protects consumers from having their private health data exploited for profit.